On August 16, 2021, Yumanity Therapeutics, Inc. announced the appointment of Michael D. Wyzga as Senior Vice President of the Company, effective on August 16, 2021. Mr. Wyzga was also appointed as the Company’s principal financial officer, effective August 16, 2021. Mr. Wyzga, age 32, joins the Company from Needham & Company, where he most recently served as Healthcare Investment Banking Vice President and previously served as a Healthcare Investment Banking Associate from June 2014 to August 2021.